M. Reza Nejadnik
Papers
1
Total Citations
5
H-Index
1
About
M. Reza Nejadnik is a leading researcher in pharmaceutical formulation science, with a primary focus on the stability and quality of biologic drugs, particularly monoclonal antibodies. His work addresses critical challenges in drug delivery and compounding, where even minor handling variations can impact patient safety. Nejadnik’s most-cited study, “Aggregate Formation and Antibody Stability in Infusion Bags: The Impact of Manual and Robotic Compounding of Monoclonal Antibodies” (2023), has already garnered 5 citations, highlighting its timely relevance. This research systematically compares manual and robotic compounding methods, revealing how mechanical stress during preparation can induce protein aggregation—a key factor in immunogenicity and potency loss. By quantifying these risks, Nejadnik provides actionable insights for pharmaceutical manufacturing and clinical pharmacy practice, bridging the gap between bench science and real-world application. His contributions are vital for advancing the safe administration of biologics, especially as automated compounding becomes more prevalent. Nejadnik’s work not only deepens our understanding of protein stability but also informs regulatory guidelines and industry best practices, making him a pivotal voice in the evolving landscape of biopharmaceutical quality control.
Research Focus
Key Achievements
Top Papers
- 1